跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Obitocin Solution for Injection in Prefilled Syringe 100mcg/mL - HSA Drug Approval Details
Approvals
/
HSA
/
Obitocin Solution for Injection in Prefilled Syringe 100mcg/mL
Approved
THERAPEUTIC
Obitocin Solution for Injection in Prefilled Syringe 100mcg/mL
GP-PHARM, S.A. (SPAIN)
🇸🇬 Health Sciences Authority
Approval Date
Feb 10, 2026
Approval ID
84a2995d52cad9b2
Company
GP-PHARM, S.A. (SPAIN)
Type
Therapeutic
Approval Details
Approval Id
84a2995d52cad9b2
Drug Name
Obitocin Solution for Injection in Prefilled Syringe 100mcg/mL
Product Name
Obitocin Solution for Injection in Prefilled Syringe 100mcg/mL
Approval Number
SIN17464P
Approval Date
2026-02-10
Registrant
UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION
Route Of Administration
INTRAVENOUS, INTRAMUSCULAR
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 10, 2026
Approval ID
84a2995d52cad9b2
Type
Therapeutic
Back to HSA Approvals
